SCHEMBL8001632

SCHEMBL8001632

O=S(=O)(/C=C/c1ccccc1)N(c1cccc(Cl)c1)S(=O)(=O)/C=C/c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
PPARG P37231 4/20 0.44
NFE2L2 Q16236 8/20 0.43
MAOB P27338 4/20 0.41
MAOA P21397 3/20 0.41
EGFR P00533 1/20 0.40
MMP1 P03956 1/20 0.40
MMP2 P08253 1/20 0.40
MMP9 P14780 1/20 0.40
FBP1 P09467 1/20 0.40
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
LMNA P02545 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7998331 0.92 NFE2L2 (0.48) MAPTSMN1; SMN2NFE2L2MAOBMAOA
SCHEMBL7998334 0.86 PTGES2 (0.46) MAPTSMN1; SMN2PPARGNFE2L2MAOB
SCHEMBL7990203 0.85 NFE2L2 (0.47) NFE2L2MAOBMAOAFBP1CYP1A2
SCHEMBL8002639 0.83 NFE2L2 (0.43) MAPTSMN1; SMN2NFE2L2MAOBMAOA
SCHEMBL7990162 0.83 ALDH1A1 (0.51) MAPTSMN1; SMN2NFE2L2MAOBFBP1
SCHEMBL8002291 0.83 NFE2L2 (0.60) NFE2L2EGFRFBP1
SCHEMBL7988653 0.82 MAOB (0.41) MAPTPPARGNFE2L2MAOBMAOA
SCHEMBL7998940 0.80 NFE2L2 (0.64) NFE2L2EGFRFBP1
SCHEMBL8001633 0.78 NFE2L2 (0.50) MAPTSMN1; SMN2PPARGNFE2L2MAOB
SCHEMBL8002290 0.78 MAOB (0.47) MAPTSMN1; SMN2NFE2L2MAOBMMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009120783-A1 HIGH AFFINITY INHIBITORS OF HEPATITIS C VIRUS NS3/4A PROTEASE THE JOHNS HOPKINS UNIVERSITY (US) 2009-10-01 WO disclosed